financetom
Business
financetom
/
Business
/
Sprouts Farmers Market Q2 Earnings, Sales Rise; 2024 Guidance Boosted; Shares Jump After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sprouts Farmers Market Q2 Earnings, Sales Rise; 2024 Guidance Boosted; Shares Jump After Hours
Jul 29, 2024 2:23 PM

04:47 PM EDT, 07/29/2024 (MT Newswires) -- Sprouts Farmers Market ( SFM ) reported Q2 adjusted earnings late Monday of $0.94 per diluted share, up from $0.71 a year earlier.

Analysts polled by Capital IQ expected $0.78.

Sales in the 13 weeks ended June 30 rose to $1.89 billion from $1.69 billion a year earlier. Analysts surveyed by Capital IQ expected $1.84 billion.

In Q3, the company expects adjusted EPS of $0.71 to $0.75. Analysts expect $0.70.

Sprouts Farmers boosted guidance for full-year adjusted EPS to $3.29 to $3.37 on sales growth of 9% to 10% from adjusted EPS of $3.05 to $3.13 on sales growth of 7% to 8%.

Analysts surveyed by Capital IQ expect normalized EPS of $3.13 on revenue of $7.4 billion.

Shares of the company jumped 14% in recent after-hours activity.

Price: 96.18, Change: +11.52, Percent Change: +13.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Recursion Pharmaceuticals Gets US FDA Clearance for Phase 1/2 Trial of REC-1245 in Solid Tumors, Lymphoma
Recursion Pharmaceuticals Gets US FDA Clearance for Phase 1/2 Trial of REC-1245 in Solid Tumors, Lymphoma
Oct 2, 2024
08:46 AM EDT, 10/02/2024 (MT Newswires) -- Recursion Pharmaceuticals ( RXRX ) said Wednesday that the US Food and Drug Administration cleared the company's investigational new drug application for a phase 1/2 trial of REC-1245 as treatment for solid tumors and lymphoma. The trial, which is scheduled to begin in Q4, will assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and potential...
Sector Update: Consumer Stocks Lean Lower Premarket Wednesday
Sector Update: Consumer Stocks Lean Lower Premarket Wednesday
Oct 2, 2024
09:12 AM EDT, 10/02/2024 (MT Newswires) -- Consumer stocks were leaning lower premarket Wednesday as the Consumer Staples Select Sector SPDR Fund ( XLP ) fell by 0.2% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was down 0.7% recently. Nike ( NKE ) shares declined by over 7% after the company reported lower fiscal Q1 earnings...
Toyota to invest $500 million in electric air taxi company Joby Aviation
Toyota to invest $500 million in electric air taxi company Joby Aviation
Oct 2, 2024
Oct 2 (Reuters) - Toyota Motor ( TM ) said Wednesday it will invest another $500 million in Joby Aviation ( JOBY ) to support certification and commercial production of Joby's electric air taxi. The Japanese automaker's new funding is on top of $394 million in prior investments it made in Joby and is part of a strategic alliance on...
SoFi debuts platform for companies to offer expanded access to IPOs
SoFi debuts platform for companies to offer expanded access to IPOs
Oct 2, 2024
Oct 2 (Reuters) - California fintech giant SoFi is teaming up with British capital markets platform PrimaryBid Technologies to expand its initial public offering share placement business, the company told Reuters. SoFi's new directed share platform, which went live on Wednesday, is designed to allow companies raising capital to allocate a portion of their offering to employees, customers and other...
Copyright 2023-2026 - www.financetom.com All Rights Reserved